Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NONE | Common Stock | Award | +29K | +33.5% | 116K | Jun 21, 2023 | Direct | F1, F2, F3 |
Id | Content |
---|---|
F1 | Pursuant to the NorthStar Healthcare Income, Inc. (the "Company") Fifth Amended and Restated Independent Directors Compensation Plan (the "Plan"), each of the Company's independent directors receives a grant of $85,000 in restricted stock units ("Restricted Stock Units") convertible, on a one-for-one-basis, into common stock, par value $0.01, of the Company (the "Common Stock") following re-election to the Company's Board of Directors. |
F2 | The Restricted Stock Units vest quarterly over a two year period with an initial vesting date of July 1, 2023. Unless forfeited prior to the applicable vesting date, the Restricted Stock Units will be converted into shares of Common Stock on the earlier of (i) Change in Control (as defined in Section 409A of the Code) or (ii) the date of the director's "separation from service" (as defined in Section 409A of the Code). |
F3 | Pursuant to the Plan, the amount of Restricted Stock Units was determined by dividing the fixed grant value of $85,000 by the most recently disclosed net asset value of the Company's common stock, or $2.93. |
See Exhibit 24 Power of Attorney